Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract
Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract
The investigators want to verify in a randomised trial, the effectiveness of EndoClotTM in
 preventing post-procedural bleeding after EMR (Endoscopic Mucosal Resection) or ESD
 (Endoscopic Submucosal Dissection) for sessile lesions >20 mm in the right colon
Inclusion Criteria:

 -  >18 years old

 -  lesions suitable for EMR or ESD

 -  > 20 mm

 -  site in the right colon

 Exclusion Criteria:

 -  Severe cardiovascular pathologies

 -  Liver and Urinary dysfunctions

 -  Hematologic diseases

 -  Pregnancy and breast feeding

 -  impossible follow-up

 -  platelet and coagulation disorders (PLT < 50 x 109/L, INR > 2)

 -  Sensitivity or allergy to the drug